News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE)'s Baby Formula Sale is One of Six Events That Will Set the Mood for Pharma Stocks


4/18/2012 7:54:41 AM

The Wall Street Journal is reporting that Pfizer is nearing a deal to sell its nutritional business (which mainly makes baby formula) to Nestle for at least $9 billion. A sale of the business was widely expected, and is seen by many investors as a likely first step for the Brobdingnagian drug firm to spin off even more divisions, potentially eventually including its emerging business in medicines that have lost patent protection.

Read at Forbes


comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES